1. Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease
   Min Wang et al, 2020, Hepatology CrossRef
2. Contribution of Aldose Reductase-Mediated Oxidative Stress Signaling in Inflammatory Lung Diseases
   Himangshu Sonowal et al, 2019, Oxidative Stress in Lung Diseases CrossRef
3. Does the breakdown of the detoxification system for aldehydes as a result of aldose reductase upregulation lead to alcohol‐induced liver injury in humans and mice?
   Nigishi Hotta et al, 2020, Journal of Diabetes Investigation CrossRef
4. Caulerpa lentillifera improves ethanol-induced liver injury and modulates the gut microbiota in rats
   Kuan-Yu Lin et al, 2023, Current Research in Food Science CrossRef
5. Myricitrin ameliorates ethanol-induced steatosis in mouse AML12 liver cells by activating AMPK, and reducing oxidative stress and expression of inflammatory cytokines
   Jing Gao et al, 2018, Molecular Medicine Reports CrossRef
6. Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis
   Xin Chi et al, 2024, Frontiers in Pharmacology CrossRef
7. Aldose reductase inhibitor protects mice from alcoholic steatosis by repressing saturated fatty acid biosynthesis
   Chang Guo et al, 2018, Chemico-Biological Interactions CrossRef
8. Hepatoprotective Effects of the Cichorium intybus Root Extract against Alcohol-Induced Liver Injury in Experimental Rats
   Jihee Kim et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
9. Recent Progress on Fructose Metabolism—Chrebp, Fructolysis, and Polyol Pathway
   Katsumi Iizuka, 2023, Nutrients CrossRef
10. Rosmarinic acid alleviates ethanol-induced lipid accumulation by repressing fatty acid biosynthesis
    Chang Guo et al, 2020, Food & Function CrossRef
11. Alcohol, White Adipose Tissue, and Brown Adipose Tissue: Mechanistic Links to Lipogenesis and Lipolysis
    Qing Li et al, 2023, Nutrients CrossRef
12. Aldose Reductase Inhibitors of Plant Origin in the Prevention and Treatment of Alcoholic Liver Disease: A Minireview
    Longxin Qiu et al, 2019, BioMed Research International CrossRef
13. Natural Compounds with Aldose Reductase (AR) Inhibition: A Class of Medicative Agents for Fatty Liver Disease
    Tong Wang et al, 2023, Combinatorial Chemistry & High Throughput Screening CrossRef
14. Bouchardatine analogue alleviates non‐alcoholic hepatic fatty liver disease/non‐alcoholic steatohepatitis in high‐fat fed mice by inhibiting ATP synthase activity
    Yong Rao et al, 2019, British Journal of Pharmacology CrossRef
15. The Inhibition of Aldose Reductase Accelerates Liver Regeneration through Regulating Energy Metabolism
    Chang Xian Li et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
16. Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease
    Richard J. Johnson et al, 2020, Frontiers in Aging Neuroscience CrossRef
17. Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions
    Himangshu Sonowal et al, 2021, Current Medicinal Chemistry CrossRef